Evaluation of changes and diagnostic informative of the cytokine profile in young patients with gastroesophageal reflux disease, occurring against the background of autoimmune inflammation
Journal Title: Український терапевтичний журнал - Year 2019, Vol 0, Issue 3
Abstract
Objective — to determine the general trend of changes in the indicators of systemic inflammation, interleukin 1β (IL 1β) and interleukin 18 (IL 18) in patients with gastroesophageal reflux disease and autoimmune thyroiditis in young people. Materials and methods. The study of the role and levels of IL 1β and IL 18 involved 83 young patients (students from 18 to 25 years) with gastroesophageal reflux disease (GERD) and autoimmune thyroiditis (AIT). The comparison group consisted of 30 patients with isolated GERD of the matched age, gender, and form of the disease. Results and discussion. It has shown that the GERD was accompanied by a significant increase of IL 1β levels, in association with AIT this indicator increased in 1.7 times. It was established that the value of IL 1β depended on the form of the esophageal mucosa lesions, it was more pronounced in the presence of erosion, but did not correlate with their number. In patients with GERD and AIT, the IL 18 levels were increased up to 1761.5 (1451.7; 2876.9) pg/ml, which exceeded this values for patients with isolated GERD: 614.6 (521.9; 721.8) pg/ml and control values (p < 0.05). Conclusions. The increased IL 18 levels have been reveled in patients with GERD and AIT, due to the inflammatory process in both organs and an autoimmune process in the thyroid gland. Further disease progression may occur due to the preservation of the autoimmune component. The GERD course, especially at it combination with AIT in young people, was accompanied by increased IL 1β levels in peripheral blood, thus indicating the presence of an active inflammatory process.
Authors and Affiliations
T. M. Pasiieshvili
Keywords
Related Articles
- EP ID EP666913
- DOI 10.30978/UTJ2019-3-16
- Views 105
- Downloads 0
The peculiarities of liver damage markers and lipid blood spectrum in patients with nonalcoholic steatohepatitis, osteoarthritis and obesity
Objective — to reveal the peculiarities of the course of nonalcoholic steatohepatitis (NASH) in comorbidity with osteoarthritis (OA) and obesity (OB) based on the study the blood lipid profile effects on the diseases’ co...
Galectin 3 — a novel biomarker for chronic heart failure in the patients with ischemic heart disease and concomitant gastroesophageal reflux disease
Objective — to study the role of the biomarker for chronic heart failure (CHF) Galectine 3 (Gal 3) in patients with IHD and concomitant gastroesophageal reflux disease (GERD). Materials and methods. The study involved 10...
Life and destiny of the creator of domestic insulin V. M. Kogan—Yasnyi (to the 130th anniversary of the birth)
-
The pathogenetic role of large intestine dysbiosis in the pathogenesis of the mutually burdened non-alcoholic fatty liver disease and chronic kidney disease
Objective — to establish the probable influence of the microbial state of the colon cavity (MSCC) content on the degree of steatosis and liver fibrosis in patients with non-alcoholic steatohepatitis (NASH) with obesity,...
Influence of combination of genetic haplotype of b1- and b2-adrenoreceptors on cardiac disease
Objective — to determine the prevalence and the effects of combined haplotypes of b1- and b2-adrenoreceptors genes on the course of heart failure. Materials and methods. 200 patients with heart failure were included to s...